Analyst Ratings for Rocket Pharmaceuticals (RCKT) [Buys]
RCKT Rating Summary
RCKT Price Target Summary
- Highest: $65.00 (Cantor Fitzgerald)
- Lowest: $9.00 (JPMorgan)
- Average: $44.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.00 (+85.9%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$44.00 (+85.9%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/24/2023 | Cantor Fitzgerald | N/A | New Coverage | Overweight (N/A) |
65.00 (N/A) |
17.16 (23.67) |
37.94% | Details |
| 2/1/2023 | Morgan Stanley | Michael E Ulz | New Coverage | Overweight (N/A) |
45.00 (N/A) |
21.22 (23.67) |
11.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
